.OncoC4 is taking AcroImmune-- as well as its internal professional manufacturing functionalities-- ...
.Amgen has actually discussed (PDF) the very first period 3 data on its own $400 thousand chronic ec...
.Biogen as well as UCB's rely on advancing in to period 3 astride an unsuccessful research study tri...
.Italian biotech Aptadir Therapeutics has launched along with the assurance that its pipe of preclin...
.Surge Lifestyle Sciences has actually met its goal in a Duchenne muscle dystrophy (DMD) study, plac...
.After a few years in biotech, Mike Quigley, Ph.D., is going back to the pharma fold, taking up the ...
.Achilles Rehabs has actually destroyed its strategy. The British biotech is quiting working on its ...
.Aligos Therapies is trumpeting a midstage gain in metabolic-dysfunction affiliated steatohepatitis ...
.Basilea Pharmaceutica's work developing new antifungals has actually received a considerable increa...
.Possessing actually gathered up the U.S. liberties to Capricor Rehabs' late-stage Duchenne muscular...